Effect of L-carnitine administration on erythropoietin use in thalassemic minor haemodialysis patients.
Di Iorio
Biagio R
BR
Guastaferro
Pasquale
P
Cillo
Nicola
N
Cucciniello
Emanuele
E
Bellizzi
Vincenzo
V
D002331:Carnitine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D004912:Erythrocytes / Q000187:drug effects; D004921:Erythropoietin / Q000627:therapeutic use*; D006801:Humans; D006435:Renal Dialysis; D013789:Thalassemia / Q000097:blood / Q000188:drug therapy* / Q000209:etiology; D016896:Treatment Outcome; D014511:Uremia / Q000150:complications / Q000628:therapy*; D014803:Vitamin B Complex / Q000627:therapeutic use*
D004921:Erythropoietin; D014803:Vitamin B Complex; D002331:Carnitine